tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ALKS Stock Latest News

ALKS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Pre-EarningsALKS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
24h ago
ALKS
Alkermes initiates Phase 2 clinical trial of ALKS 2680
PremiumThe Fly
Alkermes initiates Phase 2 clinical trial of ALKS 2680
6d ago
ALKS
Alkermes price target lowered to $23 from $25 at UBS
PremiumThe Fly
Alkermes price target lowered to $23 from $25 at UBS
15d ago
ALKS
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
19d ago
CUE
PTN
Alkermes narcolepsy drug ‘could be best-in-class,’ says Mizuho
PremiumThe Fly
Alkermes narcolepsy drug ‘could be best-in-class,’ says Mizuho
21d ago
ALKS
Alkermes price target raised to $50 at Jefferies after ‘excellent’ NT2 data
PremiumThe FlyAlkermes price target raised to $50 at Jefferies after ‘excellent’ NT2 data
21d ago
ALKS
Alkermes narcolepsy data better than expected, says Stifel
PremiumThe Fly
Alkermes narcolepsy data better than expected, says Stifel
21d ago
ALKS
Alkermes Reveals Promising Phase 1b Study Results
PremiumCompany Announcements
Alkermes Reveals Promising Phase 1b Study Results
21d ago
8K
ALKS
Alkermes’ ALKS 2680 improves wakefulness in Phase 1b narcolepsy study
PremiumThe Fly
Alkermes’ ALKS 2680 improves wakefulness in Phase 1b narcolepsy study
21d ago
ALKS
Alkermes presents results from long-term safety study of LYBALVI
PremiumThe Fly
Alkermes presents results from long-term safety study of LYBALVI
22d ago
ALKS
Alkermes management to meet with Piper Sandler
PremiumThe Fly
Alkermes management to meet with Piper Sandler
1M ago
ALKS
Alkermes management to meet with Piper Sandler
PremiumThe Fly
Alkermes management to meet with Piper Sandler
1M ago
ALKS
Alkermes management to meet with Piper Sandler
PremiumThe FlyAlkermes management to meet with Piper Sandler
1M ago
ALKS
Alkermes initiated with an Outperform at Baird
PremiumThe Fly
Alkermes initiated with an Outperform at Baird
1M ago
ALKS
Alkermes Expands Board, Elects Nancy Lurker as New Director
PremiumCompany Announcements
Alkermes Expands Board, Elects Nancy Lurker as New Director
2M ago
8K
ALKS
Alkermes downgraded to Sell from Neutral at UBS
PremiumThe Fly
Alkermes downgraded to Sell from Neutral at UBS
2M ago
ALKS
Alkermes price target raised to $33 from $30 at BofA
PremiumThe Fly
Alkermes price target raised to $33 from $30 at BofA
2M ago
ALKS
Alkermes price target raised to $39 from $35 at Piper Sandler
PremiumThe Fly
Alkermes price target raised to $39 from $35 at Piper Sandler
2M ago
ALKS
Alkermes price target raised to $35 from $34 at H.C. Wainwright
PremiumThe Fly
Alkermes price target raised to $35 from $34 at H.C. Wainwright
2M ago
ALKS
Alkermes sees 2024 revenue $1.5B-$1.6B, consensus $1.52B
PremiumThe FlyAlkermes sees 2024 revenue $1.5B-$1.6B, consensus $1.52B
2M ago
ALKS
Alkermes reports Q4 non-GAAP EPS 22c, consensus 51c
PremiumThe Fly
Alkermes reports Q4 non-GAAP EPS 22c, consensus 51c
2M ago
ALKS
ALKS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ALKS Earnings this Week: How Will it Perform?
3M ago
ALKS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >